1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...

1/13/2023NHC Issues 2nd Batch of the List of Drugs Subject To Focused State Rat...

1/13/2023AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...

1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...

1/13/2023Drug R&D and Product Registration News Digest January 2023 (2)

1/12/2023Information Collection on the 8th VBP Officially Initiated

1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...

1/12/2023Porton Pharma to set up biotech park in Slovenia‘s Menges

1/12/2023MNC Incubators in China (PharmaDJ)

1/12/2023Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...

1/11/2023China NMPA Approved 49 New Drugs in 2022 (PharmCube)

1/11/2023Takeda's EXKIVITY® (mobocertinib) Approved China for Patients with E...

1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...

1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...

1/11/2023Hepalink Invests $60M with TPG Biotechnology fund

1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...

1/10/2023Pfzier to Begin Producing Paxlovid in China Thru Local Partner within ...

1/10/2023Pfizer CEO Rules Out Authorizing Paxlovid Generic in China

1/10/2023Viking Thera Sues Ascletis Bio of 'Ruse' to Raid Trade Secrets

1/9/2023Fake Indian COVID-19 Medicines Flood China's Black Market

1/9/2023Pfizer's Negotiation with China for NRDL Listing of Covid Drug Paxlovi...

1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...

1/9/2023CDE Issues the List of Reference Formulations for GQCE Studies (63rd B...

1/9/2023Shionogi to Diversify Sourcing of APIs and Raw Materials Away from Ch...

1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...

1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...

1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)

1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)

1/6/2023Pfizer Reportedly in Talks with China over Paxlovid Generic

1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...

Page:59/719 Total number of articles:21546: [First][<<] [57] [58] [59] [60] [61] [>>] [End]